Visalytics
Visalytics
approved EB-2 (NIW)

PhD Candidate – Graduate Assistant

Immunology · Iran · 2025-09-29

Processing Time
197 days
Decision Date
2025-09-29
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to investigate the molecular mechanisms regulating immune responses and inflammation, specifically focusing on the regulation of CD47 through Rab4A in systemic lupus erythematosus. The work aims to develop targeted therapies that modulate immune responses for autoimmune conditions without compromising cancer immunity. This research is intended to create safer and more effective treatment options for patients in the U.S. healthcare system.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on CD47 and systemic lupus erythematosus addresses the growing prevalence of autoimmune diseases, a matter of significant national importance.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 11 publications, 242 citations, and NIH-funded research demonstrates the expertise necessary to advance the field of immunology.

3 On Balance, Beneficial to Waive Job Offer Met

The petitioner's contributions to therapeutic innovation and immune-related disorder treatments provide a benefit that outweighs the need for labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's 11 peer-reviewed journal articles, including one first-authored paper, which accumulated 242 citations. The evidence demonstrated that the work appeared in top-ranked journals and received support from the National Institutes of Health (NIH). USCIS found that the petitioner met all three Dhanasar prongs, establishing the national importance and substantial merit of the research.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Grants
Government Alignment
Original Contributions

Similar Cases

Postdoctoral Researcher

Pharmaceuticals · Egypt

WeGreened EB-2 (NIW) approved
Tennessee 646 days 2025-11-14
The petitioner proposes to examine immune system dysfunction and its relationship to serious medical conditions to uncover novel immune-targeted treatment strategies. The work focuses on identifying immunological mechanisms that inform the development of new therapeutic strategies for autoimmune disorders, cardiovascular disease, and inflammatory conditions.
View Case

Business Manager

Pharmaceuticals · China

WeGreened EB-2 (NIW) rfe approved
323 days 2025-06-16
The petitioner proposes to continue her research in the pharmaceutical industry focusing on precision medicine for autoimmune and inflammatory diseases. She utilizes multi-color flow cytometry and genetic variation analysis to identify immune pathways for the development of novel, personalized therapeutics for rare and severe immune-related conditions.
View Case

Research Scientist

Biotechnology · Slovenia

WeGreened EB-2 (NIW) approved
New York 64 days 2025-02-24
The petitioner proposes to advance the development of robust immunotherapies designed to overcome contemporary limitations such as impaired cell function and disease resistance. Her work focuses on elucidating novel molecular mechanisms of immune cells to improve patient outcomes in cancer care and autoimmune disease management.
View Case

Clinical Researcher

Research and Development · Jordan

WeGreened EB-2 (NIW) approved
New York 64 days 2025-03-04
The petitioner proposes to continue his research into the mechanistic contributions of T and B cells to the pathogenesis of immunodeficiency and immune dysregulation, aiming to identify and develop novel therapeutics for immunological diseases.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from Iran

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-09-29.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 197 days
Criteria Met 3 / 3
Evidence Types 5

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Iran All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist